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Introduction
The loss of estrogens at menopause has been associated with increases in dementia and age-related memory decline observed in aging women (Wolf & Kirschbaum, 2002; Yaffe et al., 2000) . Despite the findings of the Women's Health Initiative Memory Study (WHIMS), which demonstrated that giving estrogens alone or in combination with progesterone failed to prevent dementia in postmenopausal women (Shumaker et al., 2003; Shumaker et al., 2004) , other evidence has shown that estrogen administration can have beneficial effects on memory. For example, giving estrogen to healthy postmenopausal women can improve spatial working memory (Duff & Hampson, 2000) , object memory (Duka, Tasker, & McGowan, 2000) , and verbal memory (Kampen & Sherwin, 1994) . Research has also demonstrated the beneficial effects of the potent estrogen, 17b-estradiol (E 2 ), in rodent models. For example, E 2 administered intraperitoneally (i.p.) immediately post-training enhances both spatial reference memory in the Morris water maze (Gresack & Frick, 2006a; Heikkinen, Puolivali, Liu, Rissanen, & Tanila, 2002; Rissanen, Puolivali, van Groen, & Riekkinen, 1999 ) and novel object recognition memory (Gresack & Frick, 2006b; Luine, Jacome, & MacClusky, 2003) in mice and rats. Spatial and object memory are also enhanced by pre-training E 2 treatments administered systemically by injection or silastic capsules (Bimonte & Denenberg, 1999; Daniel, Fader, Spencer, & Dohanich, 1997; Luine, Richards, Wu, & Beck, 1998; Sandstrom & Williams, 2001; Sandstrom & Williams, 2004; Vaucher et al., 2002) . However, systemic hormone administration in women can lead to a host of physiological problems, including an increased incidence of coronary artery disease, stroke, and invasive breast cancer (Mastorakos, Sakkas, Xydakis, & Creatsas, 2006) , calling into question whether the potential benefits of E 2 on cognition outweigh the risks associated with hormone therapy.
An alternative approach to systemic hormone administration may be the specific targeting of proteins within the brain that are modulated by E 2 . For example, if the downstream effectors of E 2 could be elucidated, then therapies that directly target these proteins could be developed that would enhance memory without
